ServicenavigationHauptnavigationTrailKarteikarten


Research unit
INNOSUISSE
Project number
43016.1 IP-LS
Project title
Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.

Texts for this project

 GermanFrenchItalianEnglish
Short description
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
Anzeigen

Inserted texts


CategoryText
Short description
(German)
Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.
Short description
(English)
Discovery and development of novel anti-cancer agents by targeting oncogenic transcription factors.
Abstract
(German)
Cellestia Biotech is a clinical stage company based in Basel, Switzerland. The company is developing first-in-class innovative anti-cancer therapies by targeting undruggable transcription factors (TFs). The aim of the study is to expand pipeline by designing and developing novel anti-cancer agents.
Abstract
(English)